PER 5.00% 10.5¢ percheron therapeutics limited

investor pres announcement. , page-3

  1. 965 Posts.
    lightbulb Created with Sketch. 3
    Yes:

    - RNA based technologies seeing renewed investor and Big Pharma interest.
    - Multiple program 'shots on goal' with key value inflection points imminent.

    Nice work MD.

    Lok
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.